| Symbol |
Name |
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ADM
|
adrenomedullin
|
|
ADRA2B
|
adrenoceptor alpha 2B
|
|
AHRR
|
aryl-hydrocarbon receptor repressor
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3
|
|
ANKH
|
ANKH inorganic pyrophosphate transport regulator
|
|
ARTN
|
artemin
|
|
ASPSCR1
|
alveolar soft part sarcoma chromosome region, candidate 1
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BIRC7
|
baculoviral IAP repeat containing 7
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
CA9
|
carbonic anhydrase IX
|
|
CADM1
|
cell adhesion molecule 1
|
|
CAMTA1
|
calmodulin binding transcription activator 1
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCND1
|
cyclin D1
|
|
CCND3
|
cyclin D3
|
|
CD109
|
CD109 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CFH
|
complement factor H
|
|
CLDN6
|
claudin 6
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL5A1
|
collagen, type V, alpha 1
|
|
COX5B
|
cytochrome c oxidase subunit Vb
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSK
|
cathepsin K
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
DBT
|
dihydrolipoamide branched chain transacylase E2
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1
|
|
EGLN2
|
egl-9 family hypoxia-inducible factor 2
|
|
EGLN3
|
egl-9 family hypoxia-inducible factor 3
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
ELN
|
elastin
|
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
|
EP300
|
E1A binding protein p300
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
EZR
|
ezrin
|
|
FAM83H
|
family with sequence similarity 83, member H
|
|
FAP
|
fibroblast activation protein, alpha
|
|
FAS
|
Fas cell surface death receptor
|
|
FRZB
|
frizzled-related protein
|
|
FSCN1
|
fascin actin-bundling protein 1
|
|
FTO
|
fat mass and obesity associated
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
GAK
|
cyclin G associated kinase
|
|
GNAS
|
GNAS complex locus
|
|
GPC3
|
glypican 3
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
|
HDAC4
|
histone deacetylase 4
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMGB1
|
high mobility group box 1
|
|
HPSE
|
heparanase
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IL10
|
interleukin 10
|
|
ILK
|
integrin-linked kinase
|
|
INS
|
insulin
|
|
IRX2
|
iroquois homeobox 2
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
KDR
|
kinase insert domain receptor
|
|
KIDINS220
|
kinase D-interacting substrate, 220kDa
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LATS1
|
large tumor suppressor kinase 1
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LOX
|
lysyl oxidase
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MEF2A
|
myocyte enhancer factor 2A
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR193A
|
microRNA 193a
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLH1
|
mutL homolog 1
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP11
|
matrix metallopeptidase 11
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP8
|
matrix metallopeptidase 8
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MSH2
|
mutS homolog 2
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MYH10
|
myosin, heavy chain 10, non-muscle
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
NCOA2
|
nuclear receptor coactivator 2
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NKD2
|
naked cuticle homolog 2 (Drosophila)
|
|
NOTCH3
|
notch 3
|
|
NRG1
|
neuregulin 1
|
|
PDPN
|
podoplanin
|
|
PGR
|
progesterone receptor
|
|
PHF1
|
PHD finger protein 1
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIWIL2
|
piwi-like RNA-mediated gene silencing 2
|
|
PIWIL4
|
piwi-like RNA-mediated gene silencing 4
|
|
PLAG1
|
pleiomorphic adenoma gene 1
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PML
|
promyelocytic leukemia
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PVR
|
poliovirus receptor
|
|
RAD51
|
RAD51 recombinase
|
|
RASSF8
|
Ras association (RalGDS/AF-6) domain family (N-terminal) member 8
|
|
RB1
|
retinoblastoma 1
|
|
RBL2
|
retinoblastoma-like 2
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SIRT1
|
sirtuin 1
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLC20A1
|
solute carrier family 20 (phosphate transporter), member 1
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMARCE1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1
|
|
SOX4
|
SRY (sex determining region Y)-box 4
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPTB
|
spectrin, beta, erythrocytic
|
|
SQSTM1
|
sequestosome 1
|
|
SSTR1
|
somatostatin receptor 1
|
|
ST18
|
suppression of tumorigenicity 18, zinc finger
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STIM1
|
stromal interaction molecule 1
|
|
STS
|
steroid sulfatase (microsomal), isozyme S
|
|
T
|
T, brachyury homolog (mouse)
|
|
TAZ
|
tafazzin
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TFE3
|
transcription factor binding to IGHM enhancer 3
|
|
TFG
|
TRK-fused gene
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TIA1
|
TIA1 cytotoxic granule-associated RNA binding protein
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TRIO
|
trio Rho guanine nucleotide exchange factor
|
|
TUSC2
|
tumor suppressor candidate 2
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VGLL3
|
vestigial-like family member 3
|
|
VIM
|
vimentin
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
WT1
|
Wilms tumor 1
|
|
WWTR1
|
WW domain containing transcription regulator 1
|
|
YAP1
|
Yes-associated protein 1
|
|
ZNF444
|
zinc finger protein 444
|
